A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.
Manojkumar Bupathi, MD, MS
Advertisement
Articles by Manojkumar Bupathi, MD, MS
The Oncology Decoded podcast highlighted the impact of the results from the NIAGARA trial for patients with bladder cancer in a post-ASCO GU discussion.
The Oncology Decoded podcast highlighted the impact of the results from the NIAGARA trial for patients with bladder cancer in a post-ASCO GU discussion.
Manojkumar Bupathi, MD, MS, and Ben Garmezy, MD, discuss how to optimize treatment approaches for genitourinary cancers through evaluation of real-world data, sequencing strategies, and toxicity management while working to bridge care disparities between community and academic settings.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Fast Track Designation to Novel Imaging Agent in Clear Cell RCC
2
Evaluating the EVA1 Membrane Protein as a Target for Glioblastoma Therapy
3
What is the Current State of ADC Treatment in EGFR-Amplified Glioblastoma?
4
Zanidatamab-Based Regimens Exhibit Improved PFS in Gastroesophageal Cancers
5
